Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study

Journal of the American College of Cardiology

Volumn 41, Issue 10, 2003, Pages 1690-1696

  Carlsson, Jörg ^a   Miketic, Sinisa ^a   Windeler, Jürgen ^b   Cuneo, Alessandro ^a   Haun, Sebastian ^a   Micus, Stefan ^a   Walter, Sabine ^a   Tebbe, Ulrich ^a  

^a KLINIKUM LIPPE DETMOLD   (Germany)

^b Medizinischer Dienst S ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DILTIAZEM; SOTALOL; VERAPAMIL;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLEEDING; CARDIOVERSION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0038025290     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00332-2     Document Type: Article

References (22)

1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-73.
2. Braunwald E. Shattuck Lecture: Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
4. Gallagher MM, Camm AJ. Classification of atrial fibrillation. Pacing Clin Electrophysiol 1997;20:1603-5.
5. Brodsky MA, Chun JG, Podrid PJ, et al. Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. Arch Intern Med 1996;156:2553-62.
6. Carlsson J, Neuzner J, Rosenberg YD. Therapy of atrial fibrillation: rhythm control versus rate control. Pacing Clin Electrophysiol 2000;23:891-903.
7. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet 2000;356:1789-94.
8. Laupacis A, Albers G, Dalen J, et al. Antithrombotic treatment in atrial fibrillation. Chest 1998;114:579-89S.
9. Ware JE, Jr. SF 36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
10. Bullinger M, Kirchberger I. SF 36 Fragebogen zum Gesundheitszustand. Göttingen, Germany: Hogrefe, 1998:107-14.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. AFFIRM Study Planning and Steering Committees for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management: the AFFIRM study design. Am J Cardiol 1997;79:1198-202.
13. Wyse DG. The AFFIRM trial: main trial and substudies - what can we expect? J Interv Card Electrophysiol 2000;4:171-6.
14. The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM study. Am Heart J 2002;143:991-1001.
15. SoRelle R. Cardiovascular news. Late breaking trials from the American College of Cardiology. Circulation 2002;105:e9085.
16. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 1994;343:687-91.
17. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993;342:1255-62.
18. Lüderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med 2000;160:1749-57.
19. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrences of atrial fibrillation. N Engl J Med 2000;342:13-20.
20. Van Gelder IC, Crijns HJGM, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996;156:2585-92.
21. Weinberg BA, Miles WM, Klein LS, et al. Five-year follow-up of 589 patients treated with amiodarone. Am Heart J 1993;125:109-20.
22. Savelieva I, Camm AJ. Silent atrial fibrillation - another Pandora's box. Pacing Clin Electrophysiol 2000;23:145-8.